Thirty Respiratory Limited

This early-stage study is testing the safety and initial effectiveness of a new inhaled nitric oxide treatment called RESP30X. It is for adults with a lung condition called non-cystic fibrosis bronchiectasis who have persistent, high levels of certain bacteria in their lungs. Par…